In vitro biocompatibility performance of Physioneal

Area of Science:

• Nephrology
• Biocompatibility Studies
• Biomaterials Science

Background:

• Peritoneal dialysis (PD) is a vital renal replacement therapy.
• Concerns exist regarding membrane integrity with conventional PD solutions.
• Second-generation PD solutions aim to enhance biocompatibility.

Purpose of the Study:

• To evaluate the in vitro biocompatibility of Physioneal, a neutral pH, bicarbonate/lactate-buffered PD solution.
• To compare Physioneal's performance against conventional PD solutions in preclinical testing.

Main Methods:

• In vitro testing using leukocyte, mesothelial cell, and fibroblast cultures.
• Assessment of cell viability, proliferation, and functional responses.
• Evaluation of cytotoxicity and potential for angiogenesis and fibrosis.

Main Results:

• Physioneal demonstrated significantly improved biocompatibility compared to conventional solutions.
• Enhanced leukocyte viability and response to bacterial challenges were observed.
• Improved mesothelial cell viability, proliferation, and reduced fibrosis potential were noted.

Conclusions:

• In vitro studies confirm Physioneal's superior biocompatibility for peritoneal homeostasis.
• Physioneal preserves cell viability and function more effectively than conventional PD solutions.
• These findings support further preclinical investigation in animal models and human studies.